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Volume 60, Number 6 Abstracts 1719Conclusions: Patient survival has increased from 2005 to 2011 after
emergency AAA repair, with a signiﬁcant improvement particularly in pa-
tients who survive past the ﬁrst 24 hours. Though total complications
increased, major complications decreased over the study period, suggesting
newer techniques and patient care protocols may be improving outcomes.
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Introduction: Endovascular aneurysm repair (EVAR) for infrarenal
aortic aneurysms has largely become the standard of care for patients with
appropriate anatomy. However, the use of endovascular repair of juxtarenal
and pararenal aortic aneurysms often falls outside the instructions for use
(IFU) of the associated devices. We assessed the short-term mortality and
morbidity of EVAR for juxtarenal and pararenal aneurysms vs open aortic
repair (OAR).
Methods: We queried the American College of Surgeons National
Surgical Quality Improvement Program public use ﬁle from 2012, which
included the ﬁrst year of reported data from select centers tracking addi-
tional “procedure-targeted” variables for repair of abdominal aortic aneu-
rysms. This data speciﬁcally listed the proximal extent of the aneurysm if
documented in the operative note. We selected open or endoluminal repair
of juxtarenal or pararenal aneurysms for analysis. Juxtarenal aneurysms were
deﬁned as those that approached the renal artery origin, and pararenal aneu-
rysms were those that involved the renal artery origin. We excluded cases
that were for failed prior repairs.
Results: A total of 284 juxtarenal (n ¼ 234) and pararenal (n ¼ 50)
aneurysm repairs were identiﬁed, with 113 repaired by EVAR and 171 by
OAR. Preoperative characteristics were equivalent, except that EVAR pa-
tients were signiﬁcantly older, had a lower American Society of Anesthesiol-
ogists class, smoked less, and had a higher baseline creatinine. More than 35%
of the EVAR procedures required renal stents. Only 16.8% were repaired us-
ing fenestrated devices, implying that the other 83.2% were repaired outside
the device IFU. There was no difference in 30-day mortality between EVAR
and OAR (2.7% vs 3.5%). The 30-day morbidity was signiﬁcantly higher for
OAR compared with EVAR (76.0% vs 26.5%), with the highest contributing
morbidities including the need for perioperative transfusion (72.5% vs
15.9%), a return to the operating room (11.7% vs 1.8%), and cardiac or res-
piratory failure (17.5% vs 7.1%). The median intensive care unit and hospital
length of stay signiﬁcantly favored EVAR over OAR (Table).
Conclusions: Unlike traditional infrarenal aneurysm repair with
favorable anatomy, there is no advantage for EVAR over OAR in juxtare-
nal and pararenal aortic aneurysm repair in terms of 30-day mortality. Ad-
vantages of EVAR regarding decreased short-term morbidity and length of
stay must be weighed against the increasing evidence showing long-term
challenges with the outcomes for endoluminal repair of juxtarenal and par-
arenal aneurysm repairs occurring outside device IFU. Our data do not
support the use of EVAR as the primary modality in the approach of jux-
tarenal and pararenal aneurysms, and we suggest that OAR should remain
the gold standard.Table. Selected postoperative outcomes up to 30 days after the operation
Variable EVAR OAR P value
Procedures, No. 113 171
Length of stay, median (IQR), days
Intensive care unit 0 (0-1) 3 (2-5) <.001
Hospital 3 (1-5) 6 (8-11) <.001
30-day mortality, % 2.7 3.5 1.000
30-day morbidity (any of the following), % 26.5 76.0 <.001
Transfused #72 hours of operation, % 15.9 72.5 <.001
Return to the operating room, % 1.8 11.7 .002
Cardiac or respiratory failure, % 7.1 17.5 .012
Renal insufﬁciency or failure, % 7.1 9.4 .664
EVAR, Endovascular aneurysm repair; IQR, interquartile range; OAR,
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Introduction: Abdominal aortic aneurysm (AAA) repair in octogenar-
ians is thought to be associatedwith excessmortality, but an increasing number
of patients fall into this group.We sought to establishmortality rates for elective
and emergency repair by open and endovascular techniques in our center.
Methods: Data from consecutive patients aged $80 years undergoing
AAA repair between April 2005 and January 2014were examined. Aneurysms
were classed as ruptured, symptomatic, or elective. Demographics, procedure
type, 30-day mortality, and overall survival rates were recorded and analyzed.
Results: Ruptured AAAs were repaired in 65 patients (53 males; me-
dian age, 83 years). Open surgical repair (OSR) was performed in 32.3% (n
¼ 21) and endovascular repair (EVAR) in 67.7% (n ¼ 44). Combined 30-
day mortality was 35.4% (n ¼ 23), and was signiﬁcantly higher after OSR
(52.4% vs 27.3%; P ¼ .048). Median survival was 6 months (interquartile
range [IRQ], 0-22 months), increasing to 19 months (IQR, 6-42 months)
when deaths #30 days were excluded. Median survival in patients who lived
>30 days was signiﬁcantly higher in those who had undergone OSR (42.5 vs
11 months; P ¼ .019). Symptomatic AAAs were repaired in 30 patients (23
males; median age, 84.5 years). OSR was performed in one (3.3%), and 29
(96.7%) underwent EVAR. Thirty-day mortality was 3.3% (n ¼ 1); the
only death was in the EVAR group. Median survival was 29 months (IQR,
5-36.5 months). Elective AAA repair was performed in 131 patients (median
age, 82 years; 116 males), EVAR in 107 (81.7%, and OSR in 24 (18.3%.
Combined 30-day mortality was 2.3% (n ¼ 3), with no signiﬁcant difference
between EVAR and OSR (1.9% vs 4.2%; P ¼ .458). Median survival of pa-
tients undergoing elective repair was 19 months (IQR, 10-35 months). No
difference was seen between EVAR and OSR groups (P ¼ .113).
Conclusions: In this cohort of patients, AAA repair in both elective
and emergency settings was associated with low mortality and good survival
rates in the medium-term. For ruptured AAA, 30-day mortality rates are
signiﬁcantly lower in those undergoing EVAR, but >30 days, OSR is asso-
ciated with signiﬁcantly increased survival. No signiﬁcant difference between
EVAR and OSR was seen in the 30-day mortality rate or medium-term sur-
vival in elective patients.
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Introduction: Stroke remains the fourth leading cause of death and
the leading cause of disability in the United States. Carotid endarterectomy
(CEA) has been proven superior to medical therapy alone in decreasing the
risk of stroke in patients with high-grade stenosis of the internal carotid ar-
tery. Although CEA remains the gold standard, with low perioperative
stroke risk, carotid artery stenting (CAS) has seen progressively improved
outcomes. Operators follow general guidelines in intraoperative techniques
in CAS. However, few of those are evidence based. We believe that an
outcome-driven examination of the effect of prestent and poststent deploy-
ment ballooning is warranted.
Methods: We performed a retrospective analysis of all patients who
had CAS between 2005 and 2014 in the Vascular Quality Initiative
(VQI) database. Logistic regression analyses of the effect of different pre-
stent and poststent ballooning combinations on hemodynamic instability
and the 30-day stroke and death rate were constructed. We excluded pa-
tients who had no protection device, those who received any ballooning
prior to protection device deployment, and those who had no ballooning.
The model(s) controlled for patient age, sex, comorbidities, smoking status,
symptomatic status, history of previous ipsilateral CEA, preoperative medi-
cations (statin, aspirin, and b-blockers), lesion site (common carotid artery,
internal carotid artery, or both), and ipsilateral degree of stenosis.
Results: A total of 5379 patients had undergone CAS between 2005
and 2015, and 4166 patients remained after applying the exclusion criteria
mentioned above. Patients were a mean 6 standard deviation age of 69.7 6
9.6, men represented 63% of the data set. The overall perioperative stroke/
death rate was 3.1%. Compared with only prestent ballooning technique,
the combined prestent ballooning and poststent ballooning technique had
a 2.2-fold increase in hemodynamic instability (odds ratio, 2.2; 95% conﬁ-
dence interval, 1.6-3.1; P < .000) and 2.5-fold increase in the perioperative
